Results 1 to 10 of about 157,777 (224)

Update of antimicrobial resistance in level III and IV health institutions in Colombia between January 2018 and December 2021 [PDF]

Biomedica, 2023
Introducción. El comportamiento de la resistencia antimicrobiana es fundamental en el mejoramiento y ajuste de los programas de optimización de uso de antimicrobianos, la implementación de las guías terapéuticas y las precauciones que limitan la ...
De La Cadena E, Pallares CJ, García-Betancur JC, Porras JA, Villegas MV.   +4 more
europepmc   +3 more sources

[Public, private, and public-private partnerships to implement One Health as an action to address antimicrobial resistance in ColombiaParcerias públicas, privadas e público-privadas para a implementação da Saúde Única como uma ação contra a resistência a antimicrobianos na Colômbia]. [PDF]

Rev Panam Salud Publica, 2023
RESUMEN En este artículo se describe la importancia de las alianzas públicas y las alianzas privadas (APP) y de la articulación público-privada para hacer frente a la resistencia antimicrobiana (RAM) mediante el enfoque Una Salud. Estas alianzas se tejen
Rodríguez M, Vásquez GA, Cediel-Becerra N.   +2 more
europepmc   +2 more sources

Discordant β-Lactam Susceptibility in Clinical Staphylococcus aureus Isolates: A Molecular and Phenotypical Exploration to Detect the BORSA/MODSA Isolates in Bogotá, Colombia. [PDF]

Microorganisms
Staphylococcus aureus is a human pathogen responsible for a wide range of diseases, such as skin and soft tissue infections, pneumonia, toxic shock syndrome, and urinary tract infections. Methicillin-resistant S.
Fonseca-Fernández AL, Mancera-García MA, Leal-Castro AL, Leidy C, Rincón S, Carvajal LP, Reyes J, Ramírez AMC.   +7 more
europepmc   +2 more sources

Gut dysbiosis after successive administration of florfenicol-medicated feed alters intestinal inflammatory response and growth patterns in healthy Atlantic salmon (Salmo salar). [PDF]

Anim Microbiome
Background Successive treatments with florfenicol-medicated feed are the primary strategy for controlling bacterial diseases in salmonid production in Chile.
Camacho-Méndez K, Vásquez-Ponce F, Ramírez F, Valenzuela C, Alcalde-Rico M, López-Carvallo A, Gallardo-Matus J, Cruz-Flores R, Zarza C, Mercado L, Olivares-Pacheco J.   +10 more
europepmc   +2 more sources

Antimicrobial Stewardship Programs in Latin America and the Caribbean: A Story of Perseverance, Challenges, and Goals

Antibiotics, 2023
Antimicrobial resistance is one of the major global health threats. Antimicrobial stewardship (AMS) has been set as a priority within international action plans to combat this issue.
Natalia Restrepo-Arbeláez, Juan Carlos Garcia-Betancur, Christian Jose Pallares, María Virginia Villegas   +3 more
doaj   +1 more source

Molecular Analysis of Polymyxin Resistance among Carbapenemase-Producing Klebsiella pneumoniae in Colombia

Antibiotics, 2021
Polymyxin resistance in Klebsiella pneumoniae has been attributed to mutations in mgrB, phoPQ, pmrAB, and crrAB and to the presence of mcr plasmid-mediated genes. Herein, we describe the molecular characteristics of 24 polymyxin- and carbapenem-resistant
Elsa De La Cadena, María Fernanda Mojica, Juan Carlos García-Betancur, Tobías Manuel Appel, Jessica Porras, Christian José Pallares, Juan Sebastián Solano-Gutiérrez, Laura J. Rojas, María Virginia Villegas   +8 more
doaj   +1 more source

Microbiological and Clinical Aspects of Raoultella spp.

Frontiers in Public Health, 2021
The genus Raoultella was established in 2001. Species of Raoultella and Klebsiella share many ecological, biochemical, clinical, and microbiological features.
Tobias M. Appel, Tobias M. Appel, Natalia Quijano-Martínez, Elsa De La Cadena, María F. Mojica, María Virginia Villegas   +5 more
doaj   +1 more source

Molecular Mechanisms of Resistance to Ceftazidime/Avibactam in Clinical Isolates of Enterobacterales and Pseudomonas aeruginosa in Latin American Hospitals

mSphere, 2023
Ceftazidime-avibactam (CZA) is the combination of a third-generation cephalosporin and a new non-β-lactam β-lactamase inhibitor capable of inactivating class A, C, and some D β-lactamases. From a collection of 2,727 clinical isolates of Enterobacterales (
María Fernanda Mojica, Elsa De La Cadena, Juan Carlos García-Betancur, Jessica Porras, Isabella Novoa-Caicedo, Laura Páez-Zamora, Christian Pallares, Tobias Manuel Appel, Marcela A. Radice, Paulo Castañeda-Méndez, Ana C. Gales, José M. Munita, María Virginia Villegas   +12 more
doaj   +1 more source

Evaluation of Allplex™ Entero-DR assay for detection of antimicrobial resistance determinants from bacterial cultures

BMC Research Notes, 2020
Objective To evaluate the sensitivity and specificity of the Allplex™ Entero-DR, a quantitative PCR-based method, for the detection of β-lactamase-encoding genes and vancomycin-resistance determinants in 156 previously characterized Gram-negative bacilli
María Fernanda Mojica, Elsa De La Cadena, Adriana Correa, Tobias Manuel Appel, Christian José Pallares, María Virginia Villegas   +5 more
doaj   +1 more source

Genomic Analysis of CTX-M-Group-1-Producing Extraintestinal Pathogenic E. coli (ExPEc) from Patients with Urinary Tract Infections (UTI) from Colombia

Antibiotics, 2020
Background: The dissemination of the uropathogenic O25b-ST131 Escherichia coli clone constitutes a threat to public health. We aimed to determine the circulation of E.
Elsa De La Cadena, María Fernanda Mojica, Nathaly Castillo, Adriana Correa, Tobias Manuel Appel, Juan Carlos García-Betancur, Christian José Pallares, María Virginia Villegas   +7 more
doaj   +1 more source